Tim Luker is currently VP Emerging Technology and Innovation at Eli Lilly. He leads Lilly’s external innovation process in Europe within Global Corporate Business Development, primarily targeting transformational early-stage research across 5 therapy areas. This role also supports Lilly’s multiple external VC fund investments and runs due diligence and search and evaluation initiatives.
Tim is an experienced drug hunter with >20 years’ experience (>60 patents and publications). Prior to Lilly he worked at Shire, Polleo Pharma (founder, company acquired) and AstraZeneca.
Tim has a PhD in chemistry from the University of Southampton, carried out post-doctoral research at Universiteit Van Amsterdam and is a Prince2 qualified project manager.
